Matches in SemOpenAlex for { <https://semopenalex.org/work/W2168787182> ?p ?o ?g. }
- W2168787182 endingPage "773" @default.
- W2168787182 startingPage "767" @default.
- W2168787182 abstract "To investigate whether adverse effects data for the sponsor's product are presented more favourably in pharmaceutical industry-funded studies than in non-industry-funded studies.We conducted a systematic review of methodological evaluations that had assessed the relationship between industry funding and the reported risk of adverse effects. Searches were undertaken in 10 databases and supplemented with other sources of information such as handsearching, citation searching, checking conference proceedings and discussion with experts. Two reviewers independently screened the records and carried out data extraction for potentially relevant papers. We included studies that compared the results and interpretation of the adverse effects data according to funding source (e.g. adverse effects data in pharmaceutical industry research vs. data from nonprofit organizations, or from one manufacturer vs. another). Methodological evaluations were excluded if categories of funding source were not explicitly specified by the researchers, and if we were uncertain that industry-funded studies were present in the evaluation.The search strategy yielded 4,069 hits, of which six methodological evaluations met our inclusion criteria. One survey of 370 trials covering a wide range of topics found that trials with industry sponsors had more complete reporting of adverse effects compared with non-industry-funded trials, whereas another survey of 504 inhaled corticosteroid studies showed no apparent difference after confounding factors were adjusted for. In contrast, we found evidence from post hoc subgroup analyses involving two products where the likelihood of harm was of a lower magnitude in manufacturer-funded studies compared with nonmanufacturer-funded studies. There is also evidence from four methodological evaluations that authors with industry funding were more likely than authors without pharmaceutical funding to interpret and conclude that a drug was safe, even among studies that did find a statistically significant increase in adverse effects for the sponsored product.Our review indicates that industry funding may not be a major threat to bias in the reporting of the raw adverse effects data. However, we are concerned about potential bias in the interpretation and conclusions of industry-funded authors and studies." @default.
- W2168787182 created "2016-06-24" @default.
- W2168787182 creator A5072911500 @default.
- W2168787182 creator A5081177410 @default.
- W2168787182 date "2008-12-01" @default.
- W2168787182 modified "2023-09-23" @default.
- W2168787182 title "Is there evidence for biased reporting of published adverse effects data in pharmaceutical industry-funded studies?" @default.
- W2168787182 cites W1598602811 @default.
- W2168787182 cites W1986360186 @default.
- W2168787182 cites W1994648990 @default.
- W2168787182 cites W2023482608 @default.
- W2168787182 cites W2036496488 @default.
- W2168787182 cites W2078954487 @default.
- W2168787182 cites W2108010518 @default.
- W2168787182 cites W2113184125 @default.
- W2168787182 cites W2116153150 @default.
- W2168787182 cites W2120237184 @default.
- W2168787182 cites W2133774931 @default.
- W2168787182 cites W2135393211 @default.
- W2168787182 cites W2136284733 @default.
- W2168787182 cites W2142947341 @default.
- W2168787182 cites W2152340675 @default.
- W2168787182 cites W2163641338 @default.
- W2168787182 cites W2330587574 @default.
- W2168787182 cites W3121173933 @default.
- W2168787182 cites W4240442341 @default.
- W2168787182 cites W4362070832 @default.
- W2168787182 doi "https://doi.org/10.1111/j.1365-2125.2008.03272.x" @default.
- W2168787182 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2675760" @default.
- W2168787182 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18754841" @default.
- W2168787182 hasPublicationYear "2008" @default.
- W2168787182 type Work @default.
- W2168787182 sameAs 2168787182 @default.
- W2168787182 citedByCount "60" @default.
- W2168787182 countsByYear W21687871822012 @default.
- W2168787182 countsByYear W21687871822013 @default.
- W2168787182 countsByYear W21687871822014 @default.
- W2168787182 countsByYear W21687871822015 @default.
- W2168787182 countsByYear W21687871822016 @default.
- W2168787182 countsByYear W21687871822017 @default.
- W2168787182 countsByYear W21687871822018 @default.
- W2168787182 countsByYear W21687871822019 @default.
- W2168787182 countsByYear W21687871822021 @default.
- W2168787182 countsByYear W21687871822022 @default.
- W2168787182 countsByYear W21687871822023 @default.
- W2168787182 crossrefType "journal-article" @default.
- W2168787182 hasAuthorship W2168787182A5072911500 @default.
- W2168787182 hasAuthorship W2168787182A5081177410 @default.
- W2168787182 hasBestOaLocation W21687871822 @default.
- W2168787182 hasConcept C121955636 @default.
- W2168787182 hasConcept C126322002 @default.
- W2168787182 hasConcept C144133560 @default.
- W2168787182 hasConcept C15744967 @default.
- W2168787182 hasConcept C162118730 @default.
- W2168787182 hasConcept C17744445 @default.
- W2168787182 hasConcept C197934379 @default.
- W2168787182 hasConcept C199539241 @default.
- W2168787182 hasConcept C2777363581 @default.
- W2168787182 hasConcept C2777466982 @default.
- W2168787182 hasConcept C2779473830 @default.
- W2168787182 hasConcept C2779652045 @default.
- W2168787182 hasConcept C535046627 @default.
- W2168787182 hasConcept C71924100 @default.
- W2168787182 hasConcept C77350462 @default.
- W2168787182 hasConcept C77805123 @default.
- W2168787182 hasConcept C98274493 @default.
- W2168787182 hasConceptScore W2168787182C121955636 @default.
- W2168787182 hasConceptScore W2168787182C126322002 @default.
- W2168787182 hasConceptScore W2168787182C144133560 @default.
- W2168787182 hasConceptScore W2168787182C15744967 @default.
- W2168787182 hasConceptScore W2168787182C162118730 @default.
- W2168787182 hasConceptScore W2168787182C17744445 @default.
- W2168787182 hasConceptScore W2168787182C197934379 @default.
- W2168787182 hasConceptScore W2168787182C199539241 @default.
- W2168787182 hasConceptScore W2168787182C2777363581 @default.
- W2168787182 hasConceptScore W2168787182C2777466982 @default.
- W2168787182 hasConceptScore W2168787182C2779473830 @default.
- W2168787182 hasConceptScore W2168787182C2779652045 @default.
- W2168787182 hasConceptScore W2168787182C535046627 @default.
- W2168787182 hasConceptScore W2168787182C71924100 @default.
- W2168787182 hasConceptScore W2168787182C77350462 @default.
- W2168787182 hasConceptScore W2168787182C77805123 @default.
- W2168787182 hasConceptScore W2168787182C98274493 @default.
- W2168787182 hasIssue "6" @default.
- W2168787182 hasLocation W21687871821 @default.
- W2168787182 hasLocation W21687871822 @default.
- W2168787182 hasLocation W21687871823 @default.
- W2168787182 hasOpenAccess W2168787182 @default.
- W2168787182 hasPrimaryLocation W21687871821 @default.
- W2168787182 hasRelatedWork W1832679015 @default.
- W2168787182 hasRelatedWork W2057642787 @default.
- W2168787182 hasRelatedWork W2469772415 @default.
- W2168787182 hasRelatedWork W2608616923 @default.
- W2168787182 hasRelatedWork W2646420130 @default.
- W2168787182 hasRelatedWork W2821715270 @default.
- W2168787182 hasRelatedWork W3081949500 @default.
- W2168787182 hasRelatedWork W3083920421 @default.
- W2168787182 hasRelatedWork W3105812499 @default.